S&P 500

5.346,99

-0,11%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Millennium Pharmaceuticals (MM) (MLNM)
Millennium Pharmaceuticals (MM) (MLNM) Notícias

MLNM

Millennium Pharmaceuticals (MM) (MLNM)

Millennium Pharmaceuticals (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:MLNM

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
15/05/2008	16:50	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	18:27	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Current report filing (8-K)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	18:08	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Termination of Registration of a Class of Security under Section 12(g) (15-12G)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	17:32	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc-Notification filed by National Security Exchange to report the removal from listing a... (25-NSE)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	14:20	PR Newswire (US)	Takeda Completes Acquisition of Millennium	NASDAQ:MLNM
14/05/2008	11:02	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Ownership: Solicitation (SC 14D9/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	10:30	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended tender offer statement by Third Party (SC TO-T/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
14/05/2008	08:00	PR Newswire (US)	Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
12/05/2008	18:06	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Quarterly Report (10-Q)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
09/05/2008	03:21	PR Newswire (US)	Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
06/05/2008	17:00	PR Newswire (US)	Mergent, Inc. Announces Changes to the HealthShares(TM) Composite, Enabling Technologies, Autoimmune-Inflammation, Cancer, Cardi	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
05/05/2008	18:42	PR Newswire (US)	Standard & Poor's Announces Changes to U.S. Indices	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
02/05/2008	15:21	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
29/04/2008	09:00	PR Newswire (US)	Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
11/04/2008	18:08	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Tender offer statement by Third Party (SC TO-T)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
11/04/2008	17:19	PR Newswire (US)	Takeda Commences Cash Tender Offer for all Outstanding Shares of Millennium	NASDAQ:MLNM
10/04/2008	18:13	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Written communication by the subject company relating to a third party tender offer (SC14D9C)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	16:12	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Written communication relating to an issuer or third party (SC TO-C)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	11:26	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Securities Registration (section 12(g)) (8-A12G/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	03:15	PR Newswire (US)	Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/04/2008	03:06	PR Newswire (US)	Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
07/04/2008	14:06	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
07/04/2008	14:02	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
28/03/2008	17:41	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Amended Statement of Changes in Beneficial Ownership (4/A)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
17/03/2008	08:01	PR Newswire (US)	Millennium Expands IBD Franchise with Addition of New Development Candidate	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
13/03/2008	08:01	PR Newswire (US)	Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly D	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
12/03/2008	09:01	PR Newswire (US)	Eleventh Annual Lehman Brothers Global Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
10/03/2008	10:01	PR Newswire (US)	Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
29/02/2008	17:37	Edgar (US Regulatory)	Millennium Pharmaceuticals Inc - Annual Report (10-K)	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)
28/02/2008	19:33	PR Newswire (US)	2008 Susquehanna Healthcare Conference to Webcast Millennium Presentation	NASDAQ:MLNM	Millennium Pharmaceuticals (MM)